Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages.
about
Toxoplasma gondii-induced neuronal alterationsMetabolic and inflammatory genes in schizophrenia.A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial.Changes in Astroglial Markers in a Maternal Immune Activation Model of Schizophrenia in Wistar Rats are Dependent on Sex.Eicosanoids Derived From Arachidonic Acid and Their Family Prostaglandins and Cyclooxygenase in Psychiatric DisordersOndansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial.Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives.Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.Effects of Intermittent Fasting, Caloric Restriction, and Ramadan Intermittent Fasting on Cognitive Performance at Rest and During Exercise in Adults.Vitamin D in schizophrenia: a clinical review.Chronic lipopolysaccharide exposure induces cognitive dysfunction without affecting BDNF expression in the rat hippocampus.The "selfish brain" hypothesis for metabolic abnormalities in bipolar disorder and schizophrenia.Alteration of Cytokines Levels in the Striatum of Rats: Possible Participation in Vacuous Chewing Movements Induced by Antipsycotics.C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
P2860
Q27027025-DE0193D5-4DEF-4722-B368-317FEB579E6AQ34769260-5061C84A-1688-44E7-9914-E600F442C7D3Q35079183-240B14C0-1260-4F85-859F-5911E43B2DDFQ36400712-1A542A6A-04E5-40D8-AFAB-C9F1478722B8Q36594940-744487B9-0509-45F4-83DE-C8200FBE4CFDQ36924599-E69B5594-60E8-439E-AC23-6E4E3C96127CQ37154797-89574D18-1B85-452F-B1F5-B1127C02DA31Q38126701-2B77AEC4-B7A9-463E-BC7E-8867EC269183Q38599616-C14410FB-6C67-4C47-9D27-B4A2843D0D9AQ38696598-1ACF4183-9EB4-44EE-83C7-19ECEE5F1C74Q41942395-3A43B32D-97B6-416C-A266-D8FEC888E79CQ48394004-4676D74B-F9AB-4D4B-B484-96B6F9889CBFQ48711490-3526E458-18C6-4EC5-8532-23129602D78DQ58575852-8588CCA3-A466-4174-B91A-75E785D0B04C
P2860
Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cytokines in schizophrenia: po ...... inical and preclinical stages.
@en
type
label
Cytokines in schizophrenia: po ...... inical and preclinical stages.
@en
prefLabel
Cytokines in schizophrenia: po ...... inical and preclinical stages.
@en
P2093
P2860
P1476
Cytokines in schizophrenia: po ...... inical and preclinical stages.
@en
P2093
André Zugman
Elisa Brietzke
Elson de Miranda Asevedo
Graccielle Rodrigues da Cunha
Rodrigo Barbachan Mansur
P2860
P304
P356
10.1111/J.1440-1819.2012.02354.X
P577
2012-06-01T00:00:00Z